Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 167, Issue 5, Pages 651-663
Publisher
Wiley
Online
2014-08-21
DOI
10.1111/bjh.13092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different subsets of natural killer T cells may vary in their roles in health and disease
- (2014) Vipin Kumar et al. IMMUNOLOGY
- Targeted Delivery of α-Galactosylceramide to CD8α+Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
- (2014) Elodie Macho-Fernandez et al. JOURNAL OF IMMUNOLOGY
- Homocysteine Disrupts Outgrowth of Microvascular Endothelium by an iNOS-Dependent Mechanism
- (2014) Jamie N. Mayo et al. MICROCIRCULATION
- Immunomodulation as a therapeutic strategy in the treatment of multiple myeloma
- (2013) Constantine S. Mitsiades et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma
- (2013) Sungyoul Hong et al. IMMUNOLOGY LETTERS
- Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial
- (2013) M Bhutani et al. LEUKEMIA
- Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model
- (2013) Haneen Nur et al. PLoS One
- Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
- (2013) A A Chanan-Khan et al. Blood Cancer Journal
- NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
- (2012) S. R. Mattarollo et al. BLOOD
- Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
- (2012) J. Richter et al. BLOOD
- Expansion of Polyfunctional HIV-Specific T Cells upon Stimulation with mRNA Electroporated Dendritic Cells in the Presence of Immunomodulatory Drugs
- (2012) B. De Keersmaecker et al. JOURNAL OF VIROLOGY
- Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma
- (2011) A. De Luisi et al. CLINICAL CANCER RESEARCH
- Efficient Isolation of Mouse Liver NKT Cells by Perfusion
- (2010) Xianfeng Fang et al. PLoS One
- CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3
- (2010) Gabriele S. V. Campanella et al. PLoS One
- Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
- (2010) Renaud Grépin et al. Journal of Oncology
- Harnessing CD1d-Restricted T Cells toward Antitumor Immunity in Humans
- (2009) Natalia Neparidze et al. Annals of the New York Academy of Sciences
- Gene modulation and immunoregulatory roles of Interferonγ
- (2009) Banishree Saha et al. CYTOKINE
- Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
- (2009) H Quach et al. LEUKEMIA
- Regulation of multiple myeloma survival and progression by CD1d
- (2008) E. Spanoudakis et al. BLOOD
- The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
- (2008) Christine Galustian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy
- (2008) W. Song et al. CLINICAL CANCER RESEARCH
- CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system
- (2008) Jennifer L Matsuda et al. CURRENT OPINION IN IMMUNOLOGY
- The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
- (2008) Ling Lu et al. MICROVASCULAR RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now